{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:01:45Z","timestamp":1789682505935,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T00:00:00Z","timestamp":1379894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/oncsis.2013.32","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T09:24:30Z","timestamp":1379928270000},"page":"e72-e72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Estrogen receptor \u03b2 activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo"],"prefix":"10.1038","volume":"2","author":[{"given":"A G","family":"Manente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P V","family":"Jithesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S G","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K J","family":"O'Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Mutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"BFoncsis201332_CR1","first-page":"4258","volume":"82","author":"E Enmark","year":"1997","unstructured":"Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82: 4258\u20134265.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFoncsis201332_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm0597-493","volume":"3","author":"J\u00c5 Gustafsson","year":"1997","unstructured":"Gustafsson J\u00c5 . Estrogen receptor beta-getting in on the action? Nat Med 1997; 3: 493\u2013494.","journal-title":"Nat Med"},{"key":"BFoncsis201332_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2011.05.004","volume":"308","author":"M Mancuso","year":"2011","unstructured":"Mancuso M, Leonardi S, Giardullo P, Pasquali E, Borra F, Stefano ID et al. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways. Cancer Lett 2011; 308: 197\u2013202.","journal-title":"Cancer Lett"},{"key":"BFoncsis201332_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/clpt.2010.226","volume":"89","author":"S Nilsson","year":"2011","unstructured":"Nilsson S, Gustafsson J\u00c5 . Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011; 89: 44\u201355 Review.","journal-title":"Clin Pharmacol Ther"},{"key":"BFoncsis201332_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1535-7163.MCT-11-0960","volume":"5","author":"GR Sareddy","year":"2012","unstructured":"Sareddy GR, Nair BC, Gonugunta VK, Zhang QG, Brenner A, Brann DW et al. Therapeutic significance of estrogen receptor \u03b2 agonists in gliomas. Mol Cancer Ther 2012; 5: 1174\u20131182.","journal-title":"Mol Cancer Ther"},{"key":"BFoncsis201332_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/jm201436k","volume":"55","author":"VM Carroll","year":"2012","unstructured":"Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA . Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor \u03b2-selective ligands. J Med Chem 2012; 55: 528\u2013537.","journal-title":"J Med Chem"},{"key":"BFoncsis201332_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.neuropharm.2008.03.004","volume":"54","author":"ZA Hughes","year":"2008","unstructured":"Hughes ZA, Liu F, Platt BJ, Dwyer JM, Pulicicchio CM, Zhang G et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic\/antidepressant agent. Neuropharmacology 2008; 54: 1136\u20131142.","journal-title":"Neuropharmacology"},{"key":"BFoncsis201332_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/med.20186","volume":"31","author":"F Minutolo","year":"2011","unstructured":"Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA . Estrogen receptor \u03b2 ligands: recent advances and biomedical applications. Med Res Rev 2011; 31: 364\u2013442.","journal-title":"Med Res Rev"},{"key":"BFoncsis201332_CR9","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1073\/pnas.1117772108","volume":"108","author":"S Muthusamy","year":"2011","unstructured":"Muthusamy S, Andersson S, Kim HJ, Butler R, Waage L, Bergerheim U et al. Estrogen receptor \u03b2 and 17\u03b2-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer. Proc Natl Acad Sci USA 2011; 108: 20090\u201320094.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFoncsis201332_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrd3551","volume":"10","author":"S Nilsson","year":"2011","unstructured":"Nilsson S, Koehler KF, Gustafsson J\u00c5 . Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 2011; 10: 778\u2013792 Review.","journal-title":"Nat Rev Drug Discov"},{"key":"BFoncsis201332_CR11","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1016\/j.bmcl.2006.05.103","volume":"16","author":"DL Parker Jr","year":"2006","unstructured":"Parker DL Jr, Meng D, Ratcliffe RW, Wilkening RR, Sperbeck DM, Greenlee ML et al. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists. Bioorg Med Chem Lett 2006; 16: 4652\u20134656.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFoncsis201332_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1210\/en.2008-1355","volume":"150","author":"MJ Weiser","year":"2009","unstructured":"Weiser MJ, Wu TJ, Handa RJ . Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009; 150: 1817\u20131825.","journal-title":"Endocrinology"},{"key":"BFoncsis201332_CR13","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1016\/j.bmcl.2006.03.098","volume":"16","author":"RR Wilkening","year":"2006","unstructured":"Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML et al. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands. Bioorg Med Chem Lett 2006; 16: 3489\u20133494.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFoncsis201332_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.dld.2011.06.014","volume":"44","author":"M Marzioni","year":"2012","unstructured":"Marzioni M, Torrice A, Saccomanno S, Rychlicki C, Agostinelli L, Pierantelli I et al. An oestrogen receptor \u03b2-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. Dig Liver Dis 2012; 44: 134\u2013142.","journal-title":"Dig Liver Dis"},{"key":"BFoncsis201332_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/leu.2011.68","volume":"25","author":"K Yakimchuk","year":"2011","unstructured":"Yakimchuk K, Iravani M, Hasni MS, Rh\u00f6nnstad P, Nilsson S, Jondal M et al. Effect of ligand-activated estrogen receptor \u03b2 on lymphoma growth in vitro and in vivo. Leukemia 2011; 25: 1103\u20131110.","journal-title":"Leukemia"},{"key":"BFoncsis201332_CR16","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-08-4523","volume":"69","author":"G Pinton","year":"2009","unstructured":"Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA et al. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Cancer Res 2009; 69: 4598\u20134604.","journal-title":"Cancer Res"},{"key":"BFoncsis201332_CR17","doi-asserted-by":"publisher","first-page":"e14110","DOI":"10.1371\/journal.pone.0014110","volume":"5","author":"G Pinton","year":"2010","unstructured":"Pinton G, Thomas W, Bellini P, Manente AG, Favoni RE, Harvey BJ et al. Estrogen receptor \u03b2 exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib. PLoS One 2010; 5: e14110.","journal-title":"PLoS One"},{"key":"BFoncsis201332_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0031-1272874","volume":"32","author":"NP Campbell","year":"2011","unstructured":"Campbell NP, Kindler HL . Update on malignant pleural mesothelioma. Semin Respir Crit Care Med 2011; 32: 102\u2013110 Review.","journal-title":"Semin Respir Crit Care Med"},{"key":"BFoncsis201332_CR19","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.lungcan.2005.03.002","volume":"49","author":"L Kazan-Allen","year":"2005","unstructured":"Kazan-Allen L . Asbestos and mesothelioma: worldwide trends. Lung Cancer 2005; 49: S3\u2013S8.","journal-title":"Lung Cancer"},{"key":"BFoncsis201332_CR20","doi-asserted-by":"publisher","first-page":"12611","DOI":"10.1073\/pnas.1006542107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 2010; 107: 12611\u201312616.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFoncsis201332_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/14737140.8.2.293","volume":"8","author":"AJ Kaufman","year":"2008","unstructured":"Kaufman AJ, Pass HI . Current concepts in malignant pleural mesothelioma. Exp Rev Anticancer Ther 2008; 8: 293\u2013303 Review.","journal-title":"Exp Rev Anticancer Ther"},{"key":"BFoncsis201332_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ncponc0839","volume":"4","author":"A Tsiouris","year":"2007","unstructured":"Tsiouris A, Walesby RK . Malignant pleural mesothelioma: current concepts in treatment. Nat Clin Pract Oncol 2007; 4: 344\u2013352 Review.","journal-title":"Nat Clin Pract Oncol"},{"key":"BFoncsis201332_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. European Respiratory Society\/European Society of Thoracic Surgeons Task Force. Eur Respir J 2010; 35: 479\u2013495.","journal-title":"Eur Respir J"},{"key":"BFoncsis201332_CR24","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.ejca.2012.05.018","volume":"48","author":"JK Blayney","year":"2012","unstructured":"Blayney JK, Ceresoli GL, Castagneto B, O'Brien ME, Hasan B, Sylvester R et al. Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. Eur J Cancer 2012; 48: 2983\u20132992.","journal-title":"Eur J Cancer"},{"key":"BFoncsis201332_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1378\/chest.08-2665","volume":"136","author":"M Ray","year":"2009","unstructured":"Ray M, Kindler HL . Malignant pleural mesothelioma: an update on biomarkers and treatment. Chest 2009; 136: 888\u2013896 Review.","journal-title":"Chest"},{"key":"BFoncsis201332_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA . Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591\u20131603.","journal-title":"N Engl J Med"},{"key":"BFoncsis201332_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029\u20131033 Review.","journal-title":"Science"},{"key":"BFoncsis201332_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV . Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325\u2013337 Review.","journal-title":"Nat Rev Cancer"},{"key":"BFoncsis201332_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.tibs.2009.12.001","volume":"35","author":"NM Gr\u00fcning","year":"2010","unstructured":"Gr\u00fcning NM, Lehrach H, Ralser M . Regulatory crosstalk of the metabolic network. Trends Biochem Sci 2010; 35: 220\u2013227 Review.","journal-title":"Trends Biochem Sci"},{"key":"BFoncsis201332_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J . Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472\u2013482.","journal-title":"Cancer Cell"},{"key":"BFoncsis201332_CR31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","volume":"1807","author":"C Jose","year":"2011","unstructured":"Jose C, Bellance N, Rossignol R . Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 2011; 1807: 552\u2013561.","journal-title":"Biochim Biophys Acta"},{"key":"BFoncsis201332_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fphar.2011.00049","volume":"2","author":"PE Porporato","year":"2011","unstructured":"Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P . Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2011; 2: 49.","journal-title":"Front Pharmacol"},{"key":"BFoncsis201332_CR33","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1124\/mol.110.070342","volume":"79","author":"S Dr\u00f6se","year":"2011","unstructured":"Dr\u00f6se S, Bleier L, Brandt U . A common mechanism links differently acting complex II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen species production. Mol Pharmacol 2011; 79: 814\u2013822.","journal-title":"Mol Pharmacol"},{"key":"BFoncsis201332_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mito.2007.02.001","volume":"7","author":"IP Hargreaves","year":"2007","unstructured":"Hargreaves IP, Duncan AJ, Wu L, Agrawal A, Land JM, Heales SJ . Inhibition of mitochondrial complex IV leads to secondary loss complex II-III activity: implications for the pathogenesis and treatment of mitochondrial encephalomyopathies. Mitochondrion 2007; 7: 284\u2013287.","journal-title":"Mitochondrion"},{"key":"BFoncsis201332_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/ars.2011.4244","volume":"19","author":"G Benard","year":"2012","unstructured":"Benard G, Trian T, Bellance N, Berger P, Lavie J et al. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid Redox Signal 2012, epub ahead of print Apr 19: 350\u2013365.","journal-title":"Antioxid Redox Signal"},{"key":"BFoncsis201332_CR36","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1073\/pnas.0308710100","volume":"101","author":"A Hansson","year":"2004","unstructured":"Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci USA 2004; 101: 3136\u20133141.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFoncsis201332_CR37","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/jcp.23021","volume":"227","author":"S Michel","year":"2011","unstructured":"Michel S, Wanet A, De Pauw A, Rommelaere G, Arnould T, Renard P . Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J Cell Physiol 2011; 227: 2297\u20132310.","journal-title":"J Cell Physiol"},{"key":"BFoncsis201332_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1535-7163.MCT-07-0482","volume":"7","author":"B Clem","year":"2008","unstructured":"Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 2008; 7: 110\u2013120.","journal-title":"Mol Cancer Ther"},{"key":"BFoncsis201332_CR39","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1074\/jbc.M311876200","volume":"279","author":"KS Oyedotun","year":"2004","unstructured":"Oyedotun KS, Lemire BD . The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. J Biol Chem 2004; 279: 9424\u20139431.","journal-title":"J Biol Chem"},{"key":"BFoncsis201332_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/jnnp.2005.067041","volume":"77","author":"R Horv\u00e1th","year":"2006","unstructured":"Horv\u00e1th R, Abicht A, Holinski-Feder E, Laner A, Gempel K, Prokisch H et al. Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 2006; 77: 74\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFoncsis201332_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49\u201354.","journal-title":"Am J Hum Genet"},{"key":"BFoncsis201332_CR42","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43: 668\u2013672.","journal-title":"Nat Genet"},{"key":"BFoncsis201332_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/BJ20091714","volume":"428","author":"D Fornuskova","year":"2010","unstructured":"Fornuskova D, Stiburek L, Wenchich L, Vinsova K, Hansikova H, Zeman J . Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b. Biochem. J 2010; 428: 363\u2013374.","journal-title":"Biochem. J"},{"key":"BFoncsis201332_CR44","first-page":"199","volume":"31","author":"R Hayashi","year":"2004","unstructured":"Hayashi R . Expression and regulation of an estrogen-responsive gene, cytochrome c oxidase subunit 7a related polypeptide (COX7RP) in endometrial cancer. Saitama Ika Daigaku Zasshi 2004; 31: 199\u2013206.","journal-title":"Saitama Ika Daigaku Zasshi"},{"key":"BFoncsis201332_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004; 61: 450\u2013458.","journal-title":"Arch Gen Psychiatry"},{"key":"BFoncsis201332_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2011.145","volume":"22","author":"Y Hu","year":"2011","unstructured":"Hu Y, Lu W, Chen G, Wang P, Chen Z, Zhou Y et al. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res 2011; 22: 399\u2013412.","journal-title":"Cell Res"},{"key":"BFoncsis201332_CR47","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/0003-4975(94)90090-6","volume":"57","author":"WR Smythe","year":"1994","unstructured":"Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ et al. Successful adenovirus mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg 1994; 57: 1395\u20131401.","journal-title":"Ann Thorac Surg"},{"key":"BFoncsis201332_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/sj.onc.1210712","volume":"27","author":"C Williams","year":"2008","unstructured":"Williams C, Edvardsson K, Lewandowski SA, Str\u00f6m A, Gustafsson JA . A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 2008; 27: 1019\u20131032.","journal-title":"Oncogene"},{"key":"BFoncsis201332_CR49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156\u2013159.","journal-title":"Anal Biochem"},{"key":"BFoncsis201332_CR50","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/nar\/gkm010","volume":"35","author":"J Chen","year":"2007","unstructured":"Chen J, Kadlubar FF, Chen JZ . DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair. Nucleic Acids Res 2007; 35: 1377\u20131388.","journal-title":"Nucleic Acids Res"},{"key":"BFoncsis201332_CR51","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1042\/BJ20101908","volume":"435","author":"D Valenti","year":"2011","unstructured":"Valenti D, Manente GA, Moro L, Marra E, Vacca RA . Altered cAMP-dependent phosphorylation of mitochondrial complex I determines deficit of the complex activity and overproduction of reactive oxygen species by mitochondria in human skin fibroblasts with chromosome 21 trisomy. Biochem J 2011; 435: 679\u2013688.","journal-title":"Biochem J"},{"key":"BFoncsis201332_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/BJ20100581","volume":"431","author":"D Valenti","year":"2010","unstructured":"Valenti D, Tullo A, Caratozzolo MF, Merafina RS, Scartezzini P, Marra E et al. Impairment of F1FO-ATPase, adenine nucleotide translocator, and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem J 2010; 431: 299\u2013310.","journal-title":"Biochem J"},{"key":"BFoncsis201332_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bcp.2004.03.008","volume":"1","author":"B Chelli","year":"2004","unstructured":"Chelli B, Lena A, Vanacore R, Da Pozzo E, Costa B, Rossi L et al. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem Pharmacol 2004; 1: 125\u2013134.","journal-title":"Biochem Pharmacol"},{"key":"BFoncsis201332_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-291X(89)91700-2","volume":"164","author":"A Maftah","year":"1989","unstructured":"Maftah A, Petit JM, Ratinaud MH, Julien R . 10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem Biophys Res Commun 1989; 164: 185\u2013190.","journal-title":"Biochem Biophys Res Commun"}],"updated-by":[{"DOI":"10.1038\/s41389-026-00639-9","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000}}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/oncsis201332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/oncsis201332","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/oncsis201332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:38:54Z","timestamp":1781789934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/oncsis201332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9]]}},"alternative-id":["BFoncsis201332"],"URL":"https:\/\/doi.org\/10.1038\/oncsis.2013.32","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,23]]},"assertion":[{"value":"5 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ExpressionOfConcern","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Editorial Expression of Concern to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41389-026-00639-9","URL":"https:\/\/doi.org\/10.1038\/s41389-026-00639-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LM received research grants from Karo Bio AB to support and develop her studies; and SN is a Karo Bio employee. The remaining authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}